DENVER, Sept. 17, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, today spotlights a major environmental threat that Kraig Biocraft Laboratories (OTCQB: KBLB), the undisputed global leader in the development and commercialization of spider silk, is ideally positioned to address. Spider silk technology offers a biodegradable, plastic-free alternative to nylon and polyester fibers, which are major generators o ...

Nylon and Polyester Are Polluting the Planet with MicroplasticsDENVER, Sept. 17, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, today spotlights a major environmental threat that Kraig Biocraft Laboratories (OTCQB: KBLB), the undisputed global leader in the development and commercialization of spider silk, is ideally positioned to address. Spider silk technology offers a biodegradable, plastic-free alternat ...

AMSilk Overview - AMSilk has transitioned to full-scale production, indicating strong commercial validation and readiness to meet market demand for biofabricated materials [1] - The company has installed dedicated production facilities at key industrial partners to manufacture its proprietary silk-based protein materials [1] Funding and Growth - AMSilk secured €52 million (approximately $61.1 million) in funding, which will be used to scale up production and establish a new industry for high-performance biotech materials [5] - The funding round was led by Athos, with participation from MIG Capital and Novo Holdings, combining $35.25 million in equity and $22.85 million in convertible bonds, reflecting strong investor confidence [4] Production Agreements and Strategy - AMSilk has entered into multi-year production agreements to establish a long-term basis for industrial output and supply reliability [2] - The company is focused on creating robust processes and resilient supply chains to deliver on its industrial commitments and scale its biomaterials for global markets [3]

Core Insights - Eastman Chemical Company (EMN) has formed a strategic partnership with Huafon Chemical to establish a joint manufacturing facility in China, focusing on localized production and innovation of Naia cellulose acetate filament yarns [1][2]. Company Developments - The partnership enhances EMN's market presence in China, the largest textile supply-chain hub, allowing for a quicker supply-chain response to the rising demand for sustainable textile solutions [2]. - This collaboration is expected to increase EMN's production capacity and improve innovation and product development capabilities for Naia yarns, aligning with the company's goal of making sustainable textiles more accessible [2][3]. - The joint facility will utilize local advantages and international resources to create a fully integrated localized chain that encompasses technological innovation, product development, production, and services [3]. Market Context - EMN's stock has experienced a decline of 32.1% over the past year, compared to a 20.6% decline in the industry [5]. - The company is navigating a challenging global macroeconomic environment, with cautious customer behavior due to changing tariffs and soft demand [6]. - EMN anticipates benefits from cost-reduction initiatives and increased revenues from its Kingsport methanolysis facility, projecting third-quarter adjusted earnings of approximately $1.25 per share and an operating cash flow of around $1 billion for the full year [6].